Abrdn PLC Lucid Diagnostics Inc. Transaction History
Abrdn PLC
- $62.3 Billion
- Q4 2025
A detailed history of Abrdn PLC transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Abrdn PLC holds 3,457,894 shares of LUCD stock, worth $3.73 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,457,894
Previous 2,500,000
38.32%
Holding current value
$3.73 Million
Previous $2.53 Million
47.88%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding LUCD
# of Institutions
86Shares Held
32.9MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA4.97MShares$5.37 Million0.0% of portfolio
-
Masters Capital Management LLC Atlanta, GA4MShares$4.32 Million0.15% of portfolio
-
Two Seas Capital LP Rye, NY3MShares$3.24 Million0.06% of portfolio
-
Awm Investment Company, Inc. New York, NY2.99MShares$3.23 Million0.37% of portfolio
-
Ghisallo Capital Management LLC Greenwich, CT2.96MShares$3.2 Million0.33% of portfolio
About Lucid Diagnostics Inc.
- Ticker LUCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 38,568,500
- Market Cap $41.7M
- Description
- Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...